▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Procter & Gamble Q1 23 Earnings Conference Call At 8:30 AM ET

By RTTNews Staff Writer ✉ | Published: 10/19/2022 6:00 AM ET

Procter & Gamble Co. (PG) will host a conference call at 8:30 AM ET on October 19, 2022, to discuss Q1 23 earnings results.

To access the live webcast, log on to https://www.pginvestor.com/presentations-events/default.aspx

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In February 2023

Biotech Stocks Facing FDA Decision In February 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech stocks Facing FDA Decision in January 2023

Biotech Stocks Facing FDA Decision In December 2022

Biotech Stocks Facing FDA Decision In December 2022

Latest Updates on COVID-19

Covid-19 Remains An International Emergency: WHO

U.S. Covid Metrics Signal Ease In Pandemic

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

US Covid Deaths Rise By 78% In 2 Weeks

78% Increase In US Covid Deaths In A Fortnight

Read More

COVID-19: Drugs in Development

RELATED NEWS

P&G Q2 Profit Down 7%, But Meets Estimates; Boosts FY23 Sales Outlook

Procter & Gamble Co. Q2 income drops in line with estimates

Procter & Gamble Q2 23 Earnings Conference Call At 8:30 AM ET

Procter & Gamble To Present At Morgan Stanley Global Conference; Webcast At 8:00 AM ET

Follow RTT

Editor's Pick
Most Read
Most Emailed

GE HealthCare Q4 Profit Declines

Toyota Is World's Top-selling Automaker Again

Rao's Slow Simmered Soup, Chicken & Gnocchi Recalled

Daniele Intl Recalls Ready-to-Eat Sausage Products

Chevron Q4 Profit Up 25%, But Misses Estimates

ZLINE Expands Recall Of Gas Ranges

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

Drizzilicious Mini Rice Cake Bites, Popcorn Recalled

Comcast Q4 Profit Edges Down, But Results Top Estimates

Meta To Reinstate Donald Trump's Facebook, Instagram Accounts

Almondy Chocolate Cake With Daim Recalled

Amazon Workers At UK Warehouse On Strike

Cidara: FDA Committee Recommends FDA Approve Rezafungin For Candidemia, Invasive Candidiasis

FDA Advisors Propose To Replace Primary COVID Shots With New Bivalent Shots

Biotech Stocks Facing FDA Decision In February 2023

Syros Gets Fast Track Designation In U.S. For Tamibarotene For Myelodysplastic Syndrome Treatment

Abbott Issues FY23 Earnings, Sales Growth View - Update

Lonza FY22 Profit Up, Lifts Dividend; Sees Higher FY23 Sales, Weak Margin; Plans CHF 2 Bln Buyback

Abbott Laboratories Q4 Profit Decreases, but beats estimates

Sartorius Stedim Biotech FY22 Profit Rises, Orders Down; Sees Growth In FY23; Raises FY25 Sales View

Evotec Partners With Janssen Biotech To Develop Immune-based Cancer Therapies

Resmed Inc Q2 Profit Increases, beats estimates

Sartorius FY22 Prelim Earnings, Revenue Rise

Merck's KEYTRUDA Gets FDA Approval To Treat Stage IB, II, IIIA Non-small Cell Lung Cancer Patients

Germany's Jungheinrich To Acquire U.S.-based Storage Solutions For $375 Mln

American Airlines Group Q4 Profit Tops Estimates; Achieves Record Revenue

OSI Systems Q2 Profit Down, But Above Estimates - Update

Superdry Posts Wider Adj. Pretax Loss In H1, Revenue Up 3.6%; Revises Outlook

Volvo Group Q4 Adj. Operating Profit Rises; Adj. Net Sales Up 17%

Wetherspoon 25-week LFL Sales Up 13.1%; Cautiously Optimistic About FY Prospects

Abbott Issues FY23 Earnings, Sales Growth View - Update

Alexandria Real Estate Equities, Inc. Bottom Line Declines In Q4, misses estimates

Automatic Data Processing Inc. Q2 Profit Increases, beats estimates

KLA Corporation Q2 Profit Increases, beats estimates

GE HealthCare Gains On Improved Revenues

Norfolk Southern Corp Q4 Profit Rises, but misses estimates